AstraZeneca vaccine, EMA does not identify risk factors for blood clotting

European Bars Agency (MEA) announced today that it has not yet determined any risk factors such as age, gender or previous history of blood clotting cases reported after immunizing with AstraZeneca vaccine COVID-19. EMA reiterated that the vaccine's benefits exceed the risks, Reuters reports. She, on the other hand, warned [...]
EMA reiterated that the vaccine's benefits exceed the risks, Reuters reports.
She warned, on the other hand, that people should be aware of the rare possibility of blood clotting and should immediately seek medical help in case of symptoms.











